We are live on ! Find out more
BOUT icon

CapForce IBD Breakout Opportunities ETF

13 hedge funds and large institutions have $3.53M invested in CapForce IBD Breakout Opportunities ETF in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more capital invested

Capital invested by funds: $2.52M → $3.53M (+$1.01M)

8.63% more ownership

Funds ownership: 14.77%23.4% (+8.6%)

7% less funds holding

Funds holding: 1413 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change

BOUT Hedge Fund Activity: Q2 2022 in Review

13 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD Breakout Opportunities ETF (BOUT) for Q2 2022, worth a combined $3.53M — up 40% from $2.52M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BOUT and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.

The largest buyer was Envestnet Asset Management, opening a new position worth an estimated $1.15M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.03M sold.

  • 13 institutional investors held CapForce IBD Breakout Opportunities ETF (BOUT) as of Q2 2022, down from 14 in Q1 2022.
  • Funds reported $3.53M of CapForce IBD Breakout Opportunities ETF stock for Q2 2022, up 40% quarter-over-quarter.
  • 3 funds opened new CapForce IBD Breakout Opportunities ETF positions in Q2 2022 and 4 closed out, a net change of -1 holder.
  • The largest CapForce IBD Breakout Opportunities ETF buyer in Q2 2022 was Envestnet Asset Management, an estimated $1.15M added.
  • The largest CapForce IBD Breakout Opportunities ETF seller in Q2 2022 was Susquehanna International Group, an estimated $1.03M sold.

Based on aggregated 13F filings for Q2 2022.